Grants
Additional funding opportunities
Research Funding Opportunities
Grants Awarded for Health Sciences Research
| Title |
Type |
$ Amount | Activity | Investigator | Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| VA Medical Educational Costs | Ancillary Contract - Residency Programs | $61,636.00 | Instruction | Conrad Clemens | COM Academic Affairs | United States Department of Veterans Affairs | 06/2021 |
| Rapid Immunoassay for Diagnosis of Coccidioidomycosis | Contract | $49,999.00 | Research | John Galgiani | Valley Fever Ctr for Excellnc | DxDiscovery | 09/2020 |
| Work Order to the Master Subaward Agreement for Non-Industry Funding Sources between Public Health Institute (PHI) Contracting on behalf of the Children's Oncology Group (COG) | Contract | $750,000.00 | Clinical Trial | Holly Pariury | Cancer Center Division | Public Health Institute | 03/2022 |
| Product Development of the Vertical Integrated Flow Assay System Technology ("VERIFAST") for Multiplex Pathogens Detection | Contract | $4,364,034.00 | Research | Frederic Zenhausern | COM Phx NanoBioscience & Med | Advanced Technology International | 04/2020 |
| A Phase 3 Open-label Study Evaluating the Longterm Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 2 Years and Older | Contract | $484,469.00 | Clinical Trial | Cori Daines | Asthma/Airway Disease Rsch Ctr | Vertex Pharmaceuticals, Incorporated | 02/2022 |
| A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects with Heart Failure with Reduced Ejection Fraction... | Contract | $105,851.40 | Clinical Trial | Aaron Wolfson | Sarver Heart Center | Cytokinetics, Incorporated | 09/2020 |
| Carmat Total Artificial Heart Early Feasibility Study | Contract | $236,322.20 | Clinical Trial | Radha Gopalan | COM Phx Internal Medicine | Carmat (FRANCE) | 03/2021 |
| A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Single Dose of Exebacase in Patients Receiving Standard-of-Care Antibiotics for the Treatment of Staphylococcus aur | Contract | $82,971.76 | Clinical Trial | Tanya Anand | Surgery | ContraFect Corp | 01/2022 |
| Clinical Study of the BioVentrix Revivent TC System for Treatment of Left Ventricular Aneurysms | Contract | $194,732.72 | Clinical Trial | Ashish Pershad | COM Phx Internal Medicine | BioVentrix, Inc. | 08/2020 |
| Prognostic Gene Expression Profiling and Adjuvant Therapy in Stage IIIA-B Cutaneous Melanoma (PERSONALize) | Contract | $146,718.00 | Clinical Trial | Jennifer Erdrich | Cancer Center Division | Castle Biosciences Incorporated | 02/2021 |
| An Open-label, Phase 1, First-in-human, Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Maximum Tolerated or Administered Dose, Pharmacokinetics, Pharmacodynamics and Tumor.. | Contract | $2,247,249.52 | Clinical Trial | Ricklie Julian | Cancer Center Division | Bayer Pharmaceutical | 04/2021 |
| A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of MEDI3506 in Participants with Moderate to Severe Chronic Obstructive Pulmonary Disease | Contract | $164,816.08 | Clinical Trial | Eugene Bleecker | Asthma/Airway Disease Rsch Ctr | Medimmune, Incorporated (United Kingdom) | 12/2021 |
| COVID-19 Vaccines for Urban Dwelling American Indians | Contract | $858.35 | Other Sponsored Activity | Ronald Sorensen | Family and Community Medicine | Tucson Indian Center | 06/2021 |
| National Curriculum in Developmental Medicine ("NCIDM") Project | Contract | $25,000.00 | Other Sponsored Activity | Tamsen Bassford | Family and Community Medicine | American Academy of Developmental Medicine & Dentistry | 03/2020 |
| IPA Agreement for Dr. Ashwani Gupta | Contract | $75,884.00 | Research | Ashwani Gupta | Surgery | United States Department of Veterans Affairs | 07/2020 |
| UA-Altbach-Body-NAFLD-MR-2021 | Contract | $48,344.00 | Research - Industry (62.5% MTDC) | Maria Altbach | Medical Imaging | Siemens Medical Solutions USA | 10/2021 |
| Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY) | Contract | $159,936.00 | Clinical Trial | Pavani Chalasani | Cancer Center Division | IQVIA RDS Inc. | 02/2020 |
| Elecestrant Monotherapy VS. Standard Of Care For The Treatment Of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, OPEN-LABEL, Active-Controlled | Contract | $369,650.07 | Clinical Trial | Pavani Chalasani | Cancer Center Division | Radius Health, Inc. | 02/2020 |
| Research on Arizona's Response to Sexual Violence Against Children and Adults with Intellectual and Developmental Disabilities | Contract | $99,829.00 | Research | Lynne Tomasa | Family and Community Medicine | Arizona Developmental Disabilities Planning Council | 06/2020 |
| SBIR OTA FA8649-20-9-9145 Raman COVID screener | Contract | $70,000.00 | Research | Kurt Denninghoff | Dept of Emergency Medicine | Botanisol Analytics, Inc. | 09/2020 |
| Work Order to the Master Subaward Agreement for Non-Industry Funding Sources between Public Health Institute, Contracting on behalf of The Children's Oncology Group | Contract | $750,000.00 | Clinical Trial | Holly Pariury | Cancer Center Division | Public Health Institute | 03/2022 |
| A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-r | Contract | $930,117.52 | Clinical Trial | Franz Rischard | Medicine | Acceleron Pharmaceuticals | 02/2022 |
| The Automated Diseases Activity Monitoring System (ADAMS) | Contract | $824,548.00 | Research - Industry (62.5% MTDC) | Frederic Zenhausern | COM Phx NanoBioscience & Med | Costa Devices Limited | 10/2020 |
| A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Hospitalized Patients with COVID-19 | Contract | $450,320.00 | Clinical Trial | Marilyn Glassberg Csete | COM Phx Internal Medicine | Regeneron Pharmaceuticals, Inc | 12/2020 |
| Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia (The PROMISE II Trial) | Contract | $251,024.00 | Clinical Trial | Wei Zhou | Surgery | LimFlow, Inc. | 02/2022 |